The cysteine proteinase inhibitor Z-Phe-Ala-CHN2 alters cell morphology and cell division activity of Trypanosoma brucei bloodstream forms in vivo
Author:
Publisher
Springer Science and Business Media LLC
Subject
General Immunology and Microbiology
Link
https://link.springer.com/content/pdf/10.1186/1475-9292-6-2.pdf
Reference27 articles.
1. Fairlamb AH: Chemotherapy of human African trypanosomiasis: current status and future prospects. Trends Parasitol. 2003, 19: 488-494. 10.1016/j.pt.2003.09.002.
2. [http://merops.sanger.ac.uk/]
3. Rawlings ND, Morton FR, Barrett AJ: MEROPS: the peptidase database. Nucleic Acids Res. 2006, 34: D270-D272. 10.1093/nar/gkj089.
4. Scory S, Caffrey CR, Stierhof Y-D, Ruppel A, Steverding D: Trypanosoma brucei : killing of bloodstream forms in vitro and in vivo by the cysteine proteinase inhibitor Z-Phe-Ala-CHN2. Exp Parasitol. 1999, 91: 327-333. 10.1006/expr.1998.4381.
5. Troeberg L, Morty RE, Pike RN, Lonsdale-Eccles JD, Palmer TJ, McKerrow JH, Coetzer THT: Cysteine proteinase inhibitors kill cultured bloodstream forms of Trypanosoma brucei brucei. Exp Parasitol. 1999, 91: 349-355. 10.1006/expr.1998.4386.
Cited by 25 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Histopathological changes and oxidative damage in hepatic tissue of rats experimentally infected with Babesia bigemina;Polish Journal of Veterinary Sciences;2023-07-26
2. Mode of Action on Trypanosoma and Leishmania spp.;Sesquiterpene Lactones;2018
3. The Cytological Events and Molecular Control of Life Cycle Development of Trypanosoma brucei in the Mammalian Bloodstream;Pathogens;2017-06-28
4. Novel Therapeutic Targets for Human African Trypanosomiasis;Current Treatment Options in Infectious Diseases;2017-05-11
5. Chemotherapeutic Approaches Against Trypanosoma evansi: Retrospective Analysis, Current Status and Future Outlook;Current Topics in Medicinal Chemistry;2016-05-30
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3